Notably, liver steatosis and the PNPLA3 rs738409 C > G variant were associated with an increased risk for CKD, whereas the TM6SF2 rs58542926 C > T variant was associated with a reduced risk for CKD. This evidence concerns the gene PNPLA3 and chronic kidney disease.